if 1 year ago you had asked me the same question (
Post# of 36536
impossible to predict Gnbt, now we see the current 20 cents as an inconceivable value, but if we repeat the series of errors of the last year (Veneto "deal", Excellagen that does not produce revenues, first failed agreement with China, peptide tests that had to be ready by June, new toxic financing, etc ...), we could find ourselves in 1 year to hang out at these levels ..
Personally I don't take anything for granted, it is essential not to commit such a long series of debacles anymore, and to conclude something positively